FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4304185223> ?p ?o ?g. }

• W4304185223 endingPage "2087" @default.
• W4304185223 startingPage "2071" @default.
• W4304185223 abstract "Myasthenia gravis (MG) is an autoantibody-mediated autoimmune disease characterized by skeletal muscle weakness exacerbated with exercise. There is a need for novel drugs effective in refractory MG. We aimed to test the potential of teriflunomide, an immunomodulatory drug currently used in rheumatoid arthritis and multiple sclerosis treatment, in a murine experimental autoimmune myasthenia gravis (EAMG) model. EAMG was induced by immunizations with recombinant acetylcholine receptor (AChR). Teriflunomide treatment (10 mg/kg/day, intraperitoneal) was initiated to one group of mice (n = 21) following the third immunization and continued for 5 weeks. The disease control group (n = 19) did not receive medication. Naïve mice (n = 10) received only mock immunization. In addition to the clinical scorings, the numbers of B cells and T cells, and cytokine profiles of T cells were examined by flow cytometry. Anti-AChR-specific antibodies in the peripheral blood serum were quantified by ELISA. Teriflunomide significantly reduced clinical disease scores and the absolute numbers of CD4+ T cells and some of their cytokine-producing subgroups (IFN-γ, IL 2, IL22, IL-17A, GM-CSF) in the spleen and the lymph nodes. The thymic CD4+ T cells were also significantly reduced. Teriflunomide mostly spared CD8+ T cells’ numbers and cytokine production, while reducing CD138+CD19+lambda+ plasma B cells’ absolute numbers and CD138 mean fluorescent intensities, probably decreasing the number of IgG secreting more mature plasma cells. It also led to some selective changes in the measurements of anti-AChR-specific antibodies in the serum. Our results showed that teriflunomide may be beneficial in the treatment of MG in humans." @default.
• W4304185223 created "2022-10-11" @default.
• W4304185223 creator A5019094166 @default.
• W4304185223 creator A5041618714 @default.
• W4304185223 creator A5060762792 @default.
• W4304185223 creator A5074895014 @default.
• W4304185223 creator A5082010089 @default.
• W4304185223 date "2022-10-11" @default.
• W4304185223 modified "2023-09-25" @default.
• W4304185223 title "The Beneficial Clinical Effects of Teriflunomide in Experimental Autoimmune Myasthenia Gravis and the Investigation of the Possible Immunological Mechanisms" @default.
• W4304185223 cites W138141321 @default.
• W4304185223 cites W1561460904 @default.
• W4304185223 cites W1568142966 @default.
• W4304185223 cites W1610557457 @default.
• W4304185223 cites W1747802920 @default.
• W4304185223 cites W1958005161 @default.
• W4304185223 cites W1983382084 @default.
• W4304185223 cites W2003889497 @default.
• W4304185223 cites W2021245765 @default.
• W4304185223 cites W2024444969 @default.
• W4304185223 cites W2035473520 @default.
• W4304185223 cites W2043591841 @default.
• W4304185223 cites W2043948827 @default.
• W4304185223 cites W2046231107 @default.
• W4304185223 cites W2046517086 @default.
• W4304185223 cites W2049498103 @default.
• W4304185223 cites W2065357689 @default.
• W4304185223 cites W2072475795 @default.
• W4304185223 cites W2075006858 @default.
• W4304185223 cites W2076393800 @default.
• W4304185223 cites W2077671506 @default.
• W4304185223 cites W2095684825 @default.
• W4304185223 cites W2102593255 @default.
• W4304185223 cites W2107024251 @default.
• W4304185223 cites W2108207836 @default.
• W4304185223 cites W2119548239 @default.
• W4304185223 cites W2132702056 @default.
• W4304185223 cites W2133329597 @default.
• W4304185223 cites W2140767387 @default.
• W4304185223 cites W2292295104 @default.
• W4304185223 cites W2553674384 @default.
• W4304185223 cites W2604600278 @default.
• W4304185223 cites W2750731598 @default.
• W4304185223 cites W2765824083 @default.
• W4304185223 cites W2774941197 @default.
• W4304185223 cites W2776638558 @default.
• W4304185223 cites W2791874745 @default.
• W4304185223 cites W2932960192 @default.
• W4304185223 cites W2942527824 @default.
• W4304185223 cites W3031008534 @default.
• W4304185223 cites W3037209658 @default.
• W4304185223 cites W3098239695 @default.
• W4304185223 cites W3203411688 @default.
• W4304185223 doi "https://doi.org/10.1007/s10571-022-01286-5" @default.
• W4304185223 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36219379" @default.
• W4304185223 hasPublicationYear "2022" @default.
• W4304185223 type Work @default.
• W4304185223 citedByCount "0" @default.
• W4304185223 crossrefType "journal-article" @default.
• W4304185223 hasAuthorship W4304185223A5019094166 @default.
• W4304185223 hasAuthorship W4304185223A5041618714 @default.
• W4304185223 hasAuthorship W4304185223A5060762792 @default.
• W4304185223 hasAuthorship W4304185223A5074895014 @default.
• W4304185223 hasAuthorship W4304185223A5082010089 @default.
• W4304185223 hasBestOaLocation W43041852232 @default.
• W4304185223 hasConcept C126322002 @default.
• W4304185223 hasConcept C159654299 @default.
• W4304185223 hasConcept C163764329 @default.
• W4304185223 hasConcept C203014093 @default.
• W4304185223 hasConcept C2775905006 @default.
• W4304185223 hasConcept C2776036978 @default.
• W4304185223 hasConcept C2777575956 @default.
• W4304185223 hasConcept C2777703276 @default.
• W4304185223 hasConcept C2778105408 @default.
• W4304185223 hasConcept C2778690821 @default.
• W4304185223 hasConcept C2778957590 @default.
• W4304185223 hasConcept C2779075594 @default.
• W4304185223 hasConcept C2780640218 @default.
• W4304185223 hasConcept C71924100 @default.
• W4304185223 hasConceptScore W4304185223C126322002 @default.
• W4304185223 hasConceptScore W4304185223C159654299 @default.
• W4304185223 hasConceptScore W4304185223C163764329 @default.
• W4304185223 hasConceptScore W4304185223C203014093 @default.
• W4304185223 hasConceptScore W4304185223C2775905006 @default.
• W4304185223 hasConceptScore W4304185223C2776036978 @default.
• W4304185223 hasConceptScore W4304185223C2777575956 @default.
• W4304185223 hasConceptScore W4304185223C2777703276 @default.
• W4304185223 hasConceptScore W4304185223C2778105408 @default.
• W4304185223 hasConceptScore W4304185223C2778690821 @default.
• W4304185223 hasConceptScore W4304185223C2778957590 @default.
• W4304185223 hasConceptScore W4304185223C2779075594 @default.
• W4304185223 hasConceptScore W4304185223C2780640218 @default.
• W4304185223 hasConceptScore W4304185223C71924100 @default.
• W4304185223 hasFunder F4320336451 @default.
• W4304185223 hasIssue "5" @default.
• W4304185223 hasLocation W43041852231 @default.
• W4304185223 hasLocation W43041852232 @default.
• W4304185223 hasLocation W43041852233 @default.

• next